Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
- PMID: 35550651
- PMCID: PMC9102601
- DOI: 10.1186/s40779-022-00382-3
Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic interstitial lung disease with no established treatment and is characterized by progressive scarring of the lung tissue and an irreversible decline in lung function. Chronic inflammation has been demonstrated to be the pathological basis of fibrosis. Emerging studies have revealed that most interleukin-17 (IL-17) isoforms are essential for the mediation of acute and chronic inflammation via innate and adaptive immunity. Overexpression or aberrant expression of IL-17 cytokines contributes to various pathological outcomes, including the initiation and exacerbation of IPF. Here, we aim to provide an overview of IL-17 family members in the pathogenesis of IPF.
Keywords: IL-17 receptor; Idiopathic pulmonary fibrosis; Inflammation; Interleukin-17 (IL-17) family.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.Exp Lung Res. 2016;42(2):75-86. doi: 10.3109/01902148.2016.1144835. Exp Lung Res. 2016. PMID: 27070485
-
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.J Mol Med (Berl). 2021 Jan;99(1):131-145. doi: 10.1007/s00109-020-02001-x. Epub 2020 Nov 9. J Mol Med (Berl). 2021. PMID: 33169236
-
Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.Am J Pathol. 2012 May;180(5):1963-78. doi: 10.1016/j.ajpath.2012.01.010. Epub 2012 Mar 16. Am J Pathol. 2012. PMID: 22429962 Free PMC article.
-
CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential.Biomolecules. 2023 Feb 9;13(2):333. doi: 10.3390/biom13020333. Biomolecules. 2023. PMID: 36830702 Free PMC article. Review.
-
Inflammation and immunity in IPF pathogenesis and treatment.Respir Med. 2019 Feb;147:79-91. doi: 10.1016/j.rmed.2018.12.015. Epub 2019 Jan 9. Respir Med. 2019. PMID: 30704705 Review.
Cited by
-
Altered expression pattern of immune response-related genes and isoforms in hypersensitivity pneumonitis lung fibroblasts.Sci Rep. 2024 Oct 14;14(1):24002. doi: 10.1038/s41598-024-74267-x. Sci Rep. 2024. PMID: 39402115 Free PMC article.
-
The role of IL-17 and Th17 cells in keloid pathogenesis.Arch Dermatol Res. 2024 Sep 14;316(9):626. doi: 10.1007/s00403-024-03352-y. Arch Dermatol Res. 2024. PMID: 39276195
-
Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review.Int J Mol Sci. 2024 Aug 16;25(16):8946. doi: 10.3390/ijms25168946. Int J Mol Sci. 2024. PMID: 39201632 Free PMC article. Review.
-
The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections.Oxf Open Immunol. 2024 Jul 24;5(1):iqae008. doi: 10.1093/oxfimm/iqae008. eCollection 2024. Oxf Open Immunol. 2024. PMID: 39193472 Free PMC article. Review.
-
Prognostic model of fibroblasts in idiopathic pulmonary fibrosis by combined bulk and single-cell RNA-sequencing.Heliyon. 2024 Jul 11;10(14):e34519. doi: 10.1016/j.heliyon.2024.e34519. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39113997 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources